Halyard Health Inc (HYH) : Krensavage Asset Management scooped up 12,917 additional shares in Halyard Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 575,206 shares of Halyard Health Inc which is valued at $20,839,713.Halyard Health Inc makes up approximately 7.20% of Krensavage Asset Management’s portfolio.
Other Hedge Funds, Including , Cornerstone Capital Management Holdings. boosted its stake in HYH in the latest quarter, The investment management firm added 107,400 additional shares and now holds a total of 142,200 shares of Halyard Health Inc which is valued at $5,151,906. Halyard Health Inc makes up approx 0.04% of Cornerstone Capital Management Holdings.’s portfolio. Tower Research Capital (trc) added HYH to its portfolio by purchasing 3,199 company shares during the most recent quarter which is valued at $115,900. Halyard Health Inc makes up approx 0.01% of Tower Research Capital (trc)’s portfolio.Brown Advisory Inc reduced its stake in HYH by selling 70 shares or 0.88% in the most recent quarter. The Hedge Fund company now holds 7,898 shares of HYH which is valued at $284,328.Retirement Systems Of Alabama boosted its stake in HYH in the latest quarter, The investment management firm added 94 additional shares and now holds a total of 60,202 shares of Halyard Health Inc which is valued at $2,048,072. Halyard Health Inc makes up approx 0.01% of Retirement Systems Of Alabama’s portfolio.
Halyard Health Inc opened for trading at $36.47 and hit $36.91 on the upside on Monday, eventually ending the session at $36.84, with a gain of 1.18% or 0.43 points. The heightened volatility saw the trading volume jump to 1,69,156 shares. Company has a market cap of $1,719 M.
On the company’s financial health, Halyard Health Inc reported $0.45 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.36. The company had revenue of $400.00 million for the quarter, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.
Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Deutsche Bank on Aug 10, 2016 to “Buy”, Firm has raised the Price Target to $ 41 from a previous price target of $36 .Company shares were Reiterated by Stifel on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 38 from a previous price target of $37 .Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .
Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.